Longeveron Inc.LGVN

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$2.91
Market cap
$9.1M
P/E
—
Revenue (TTM)
$1.2M
Net income
-$23.5M
Dividend yield
—
1-year total return
-63.4%
Net margin
-1977.6%
Revenue growth
-42.7%
Debt / equity
—

What Longeveron Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$5.6M$1.3M$1.2M$709,000$2.4M$1.2M
Net income-$3.7M-$17.0M-$18.8M-$21.4M-$16.0M-$22.7M
Free cash flow-$2.5M-$10.0M-$14.5M-$19.3M-$14.5M-$18.9M

More on LGVN.

Figures from Longeveron Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.